DengiAll Dengue Vaccine in Phase III Trial
1 June 2026National
Panacea Biotec, overseen by ICMR, advanced Phase III clinical trials of its indigenous dengue vaccine candidate DengiAll, enrolling over 10,000 volunteers across India.
More International Current Affairs
Bud Rot Outbreak Hits Coconut Palms in Tiptur Taluk of Karnataka's Tumakuru District
GK Byte
📅 21 Oct 2026InternationalRead complete →
US Order Removing DeepSeek AI from Federal Civilian IT Systems Takes Effect on 20 October 2026
GK Byte
📅 20 Oct 2026InternationalRead complete →
Astronomers Identify WD J1330+6435, the First White Dwarf Found to Appear Chartreuse Green
GK Byte
📅 19 Oct 2026InternationalRead complete →
Samsung Semiconductor India Research and IISc Inaugurate Quantum Research Lab in Bengaluru
GK Byte
📅 17 Oct 2026InternationalRead complete →